180 Life Sciences Corp/$ETHZ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About 180 Life Sciences Corp
ETHZilla Corp Formerly 180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
Ticker
$ETHZ
Sector
Primary listing
Employees
4
Headquarters
Website
ETHZ Metrics
BasicAdvanced
$407M
-
-$6.03
0.24
-
Price and volume
Market cap
$407M
Beta
0.24
52-week high
$17.46
52-week low
$0.66
Average daily volume
21M
Financial strength
Current ratio
0.58
Quick ratio
0.418
Total debt to equity
26.251
Interest coverage (TTM)
-230.45%
Profitability
EBITDA (TTM)
-6.449
Effective tax rate (TTM)
3.12%
Management effectiveness
Return on assets (TTM)
-55.46%
Return on equity (TTM)
-371.02%
Valuation
Price to book
2.74
Price to tangible book (TTM)
-6.57
Price to free cash flow (TTM)
-2.207
Free cash flow yield (TTM)
-45.31%
Free cash flow per share (TTM)
-1.106
Growth
Earnings per share change (TTM)
-68.64%
3-year earnings per share growth (CAGR)
-71.71%
Bulls say / Bears say
ETHZilla holds 94,675 ETH, valued at around $419 million, providing a substantial on-chain asset base that sets it apart as a crypto-native public company (Investing.com).
The company raised approximately $565 million through a $425 million PIPE and $156.25 million convertible note, drawing in over 60 institutional and crypto-native investors—including Electric Capital and Polychain Capital—which demonstrates strong confidence in its Ethereum treasury strategy (Investing.com).
ETHZilla has partnered with Electric Capital as its external asset manager to run an on-chain yield generation program aimed at outperforming traditional ETH staking, positioning the company to enhance yield and diversify revenues beyond simple asset appreciation (Investing.com).
ETHZilla reported a trailing-twelve-month EBITDA loss of $6.478 million with no disclosed positive revenue streams, highlighting ongoing unprofitability despite holding significant crypto assets (CNBC).
Shares dropped nearly 30% after a filing revealed shareholders could sell up to 74.8 million convertible shares—potentially increasing the share count by around 46% and raising major dilution concerns (CoinDesk).
ETHZilla’s stock remains highly correlated with movements in Ether, with a 4% after-hours decline following a minor ETH price drop, indicating substantial exposure to crypto market volatility (Benzinga).
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2025.
ETHZ News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for 180 Life Sciences Corp stock?
180 Life Sciences Corp (ETHZ) has a market cap of $407M as of September 09, 2025.
What is the P/E ratio for 180 Life Sciences Corp stock?
The price to earnings (P/E) ratio for 180 Life Sciences Corp (ETHZ) stock is 0 as of September 09, 2025.
Does 180 Life Sciences Corp stock pay dividends?
No, 180 Life Sciences Corp (ETHZ) stock does not pay dividends to its shareholders as of September 09, 2025.
When is the next 180 Life Sciences Corp dividend payment date?
180 Life Sciences Corp (ETHZ) stock does not pay dividends to its shareholders.
What is the beta indicator for 180 Life Sciences Corp?
180 Life Sciences Corp (ETHZ) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.